Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-31

Clinical Trial Update: A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial comparing fluoxetine vs divalproex for intermittent explosive disorder has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Divalproex (divalproex sodium)
  • Fluoxetine (Fluoxetine)

Snippet

Sponsor: University of Chicago | Conditions: Intermittent Explosive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-12-31